Cedars-Sinai Digestive Disease Experts Share Latest Research and Honors at ACG 2022 Scientific Meeting

Cedars-Sinai Digestive Disease Experts Share Latest Research and Honors at ACG 2022 Scientific Meeting

Newswise – LOS ANGELES (Oct. 19, 2022) – Cedars-Sinai physicians and scientists will share the results of new research aimed at improving the treatment of digestive diseases at the American College of Gastroenterology (ACG) International Meeting. The clinical conference will take place October 21-26 in Charlotte, North Carolina, and is available for virtual and in-person participation.

Twenty-five poster presentations of studies conducted or co-authored by Cedars-Sinai researchers cover a wide range of research in digestive disorders, including irritable bowel syndrome (IBS), inflammatory bowel disease, small intestine bacterial overgrowth (SIBO), colorectal cancer screening and virtual reality for symptom management.

In addition to the research highlighted at the conference, two multicenter studies featuring the work of Cedars-Sinai scientists were recognized with the ACG Governors Award for Excellence in Clinical Research and a Presidential Poster Award.

During the conference, Cedars-Sinai experts will be available to comment on a wide variety of clinical and scientific developments in the field of digestive disease and patient care. Interviews with scientists participating in the conference in person or remotely can be arranged. For a complete list of Cedars-Sinai poster presentations or to arrange interviews, please contact Laura Coverson by phone at 310-562-1112 or by email: [email protected].

CAG 2022 Embargo Policy: All research presented at CAG 2022 is strictly embargoed until 12:00 p.m. EDT Sunday, October 23, 2022

Cedars-Sinai Research Highlights at CAG 2022 – All Times EDT

ATTACH: The association between SARS-Cov-2 stool excretion, microbiome diversity and gut inflammation. Multicenter study. Andres Yarur, MD, gastroenterologist and associate professor of medicine at Cedars-Sinai.

Monday, Oct. 24, 10 a.m.-12 p.m.

ATTACH: Symptomatic response to antibiotics in patients with small intestinal bacterial overgrowth: a systematic review and meta-analysis. Multicenter study. Mark Pimentel, MD, executive director of the Medically Associated Science and Technology Program, and Ali Rezaie, MD, medical director of GI Motility.
Monday, Oct. 24, 10 a.m.-12 p.m.

AGC Governors Awards
ORAL: Virtual Reality Improves Symptoms of Functional Dyspepsia: Results of a Randomized, Controlled, Double-Blind Pilot Study. Multicenter study. Mayo Clinic, Jacksonville, Florida, and Cedars-Sinai. Brennan Spiegel, MD, MSHS, director of health services research at Cedars-Sinai. Oral presentation by David Cangemi, MD, Mayo Clinic.
Monday, October 24, 8:24 a.m.

AGC Presidential Poster Award

ATTACH: Clinical utility of precision guided dosing tool for infliximab during maintenance treatment of inflammatory bowel disease. Multicenter study. Shervin Rabizadeh, MD, MBA, Director, Pediatric Gastroenterology and Inflammatory Bowel Disease, and Chair of Guerin Children’s Department of Pediatrics, and Gil Melmed, MD, Director of Clinical Research, Inflammatory Bowel Disease.
Monday, October 24, 3-5 p.m.

ATTACH: Is the fecal immunochemical test (FIT) the answer to the increased use of colorectal cancer (CRC) screening in the Filipino community? Results of a conjoint analysis survey.
Christopher V. Almario, MD, MSHPM, assistant professor of medicine at Cedars-Sinai.
Monday, October 24, 3-5 p.m.

ATTACH: Evaluation of multiple dosing regimens of proton pump inhibitors (PPIs) for the treatment of gastroesophageal reflux disease (GERD): systematic review and meta-analysis. Gillian Gresham, PhD, Research Scientist, Cedars-Sinai and Brennan Spiegel, MD, MSHS, Director of Health Services Research at Cedars-Sinai.
Tuesday, Oct. 25, 10 a.m.-12 p.m.

Similar Posts

Leave a Reply

Your email address will not be published.